...
首页> 外文期刊>The Prostate >The 25th Annual Prostate Cancer Foundation Scientific Retreat Report
【24h】

The 25th Annual Prostate Cancer Foundation Scientific Retreat Report

机译:第25届年前前列腺癌基础科学撤退报告

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: The 25th Annual Prostate Cancer Foundation (PCF) Scientific Retreat was held in Carlsbad, CA, from 26 to 28 October 2018. Methods: The PCF Scientific Retreat is the foremost scientific research conference in the world that focuses on the most significant and promising recent advancements in basic, translational, and clinical prostate cancer research, as well as research from other fields that has substantial potential to advance prostate cancer research. Results: The major topic areas discussed at this year's meeting included (a) new insights into prostate cancer biology and treatment; (b) approaches for accelerating precision medicine for prostate cancer; (c) prostate-specific membrane antigen-targeted therapy and imaging for prostate cancer; (d) updates on Poly (ADP-ribose) polymerase (PARP)-inhibitor clinical trial results; (e) the biology and role of prostate cancer stem cells; (f) new approaches for targeting the androgen receptor and other steroid hormone receptor pathways; (g) racial disparities in prostate cancer treatment and outcomes; (h) the role of the nervous system in prostate cancer development and progression; (i) the role of the WNT signaling pathway in normal prostate and prostate cancer biology; (j) novel immunotherapy approaches; and (k) the ecology of prostate cancer. Conclusions: This article reviews the research presented by the speakers at the 2018 PCF Scientific Retreat for the purpose of disseminating this knowledge to the global research community and ultimately accelerating new understandings and treatment strategies for prostate cancer.
机译:背景:第25届年前前列腺癌基础(PCF)科学撤退于2018年10月26日至28日在CARLSBAD举行。方法:PCF科学撤退是世界上最重要的科研会议,专注于最重要和最有前途基础,翻译和临床前列腺癌研究的最新进展,以及其他领域的研究,具有推进前列腺癌研究的大量潜力。结果:在今年会议上讨论的主要主题领域包括(a)新见解前列腺癌生物学和治疗; (b)加速前列腺癌精密药物的方法; (c)前列腺特异性膜抗原靶向治疗和成像前列腺癌; (d)对聚(ADP-核糖)聚合酶(PARP)的更新 - 抑制临床试验结果; (e)前列腺癌干细胞的生物学和作用; (f)靶向雄激素受体和其他类固醇激素受体途径的新方法; (g)前列腺癌治疗和结果的种族差异; (h)神经系统在前列腺癌发展和进展中的作用; (i)Wnt信号通路在正常前列腺和前列腺癌生物学中的作用; (j)新型免疫疗法方法; (k)前列腺癌的生态。结论:本文审查了2018年PCF科学撤退的发言人提出的研究,目的是向全球研究界传播这些知识,并最终加速前列腺癌的新谅解和治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号